Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...
AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback